PD-L1 regulation depends on the Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathways controlled by MAPK pathways, and its expression is increased in BRAF and MEK inhibitor-resistant metastatic melanomas. The gene discussed is SOAT1; the disease is metastatic melanoma.